Education
About Us
Working with TipRanks
Follow Us
AnGes Inc (JP:4563)
:4563
4563 Stock Chart & Stats
Day’s Range― - ―
52-Week Range¥45.00 - ¥98.00
Previous CloseN/A
Volume2.84M
Average Volume (3M)5.14M
Market Cap
$20.82B
Enterprise Value¥18.37B
Total Cash (Recent Filing)$1.71B
Total Debt (Recent Filing)¥271.00M
Price to Earnings (P/E)―
Beta0.37
Next Earnings
Aug 08, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.99
Shares Outstanding352,955,540
10 Day Avg. Volume4,289,780
30 Day Avg. Volume5,142,756
Financial Highlights & Ratios
PEG Ratio-0.14
Price to Book (P/B)5.74
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$63.38Price Target Upside5.63% Upside
Rating ConsensusHold
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
<0.01%
Mutual Funds
― Other Institutional Investors
99.80% Public Companies and
Individual Investors
4563 FAQ
What was AnGes Inc’s price range in the past 12 months?
AnGes Inc lowest stock price was ¥45.00 and its highest was ¥98.00 in the past 12 months.
What is AnGes Inc’s market cap?
AnGes Inc’s market cap is $20.82B.
When is AnGes Inc’s upcoming earnings report date?
AnGes Inc’s upcoming earnings report date is Aug 08, 2025 which is in 22 days.
How were AnGes Inc’s earnings last quarter?
Currently, no data Available
Is AnGes Inc overvalued?
According to Wall Street analysts AnGes Inc’s price is currently Undervalued.
Does AnGes Inc pay dividends?
AnGes Inc does not currently pay dividends.
What is AnGes Inc’s EPS estimate?
AnGes Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does AnGes Inc have?
AnGes Inc has 352,955,540 shares outstanding.
What happened to AnGes Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of AnGes Inc?
Currently, no hedge funds are holding shares in JP:4563
Company Description
AnGes Inc
AnGes, Inc. (4563) is a biotechnology company headquartered in Japan, specializing in the development and commercialization of gene-based medicines. The company's core focus is on the research and development of innovative therapies targeting genetic and rare diseases, cardiovascular diseases, and infectious diseases. AnGes is dedicated to advancing its proprietary gene therapy technologies and enhancing its product pipeline to address unmet medical needs globally.
Technical Analysis
CanBas Co., Ltd.
―
Healios KK
―
StemRIM Inc.
―
Japan Tissue Engineering Co., Ltd.
―
CellSeed Inc.
―